ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | -13.3% | 285 | -53.3% | 0.01% | -12.5% |
| Q1 2019 | $15,000 | +15.4% | 610 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $13,000 | +18.2% | 610 | -15.3% | 0.01% | +16.7% |
| Q3 2018 | $11,000 | -8.3% | 720 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $12,000 | 0.0% | 720 | -2.7% | 0.01% | 0.0% |
| Q1 2018 | $12,000 | +33.3% | 740 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $9,000 | -99.9% | 740 | +27.6% | 0.01% | -37.5% |
| Q3 2017 | $13,407,000 | +47.0% | 580 | -46.8% | 0.01% | +33.3% |
| Q2 2017 | $9,123,000 | -1.4% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $9,254,000 | +92440.0% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $10,000 | +150.0% | 1,090 | 0.0% | 0.01% | +100.0% |
| Q2 2016 | $4,000 | +100.0% | 1,090 | +113.7% | 0.00% | +200.0% |
| Q1 2016 | $2,000 | – | 510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
| BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
| First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
| Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
| EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
| Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
| NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
| Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
| Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
| KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |